Progress and challenges of confirmatory trials for cancer drugs granted conditional approval in China

Saved in:
Bibliographic Details
Main Authors: Xingxian Luo, Yang Xu, Xin Du, Xufeng Lv, Si Chen, Yue Yang, Lin Huang, Xiaohong Zhang
Format: Article
Language:English
Published: Elsevier 2024-11-01
Series:The Lancet Regional Health. Western Pacific
Online Access:http://www.sciencedirect.com/science/article/pii/S2666606524002323
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850198316403392512
author Xingxian Luo
Yang Xu
Xin Du
Xufeng Lv
Si Chen
Yue Yang
Lin Huang
Xiaohong Zhang
author_facet Xingxian Luo
Yang Xu
Xin Du
Xufeng Lv
Si Chen
Yue Yang
Lin Huang
Xiaohong Zhang
author_sort Xingxian Luo
collection DOAJ
format Article
id doaj-art-4e47de022c884c71b4bc8da87f619c8b
institution OA Journals
issn 2666-6065
language English
publishDate 2024-11-01
publisher Elsevier
record_format Article
series The Lancet Regional Health. Western Pacific
spelling doaj-art-4e47de022c884c71b4bc8da87f619c8b2025-08-20T02:12:54ZengElsevierThe Lancet Regional Health. Western Pacific2666-60652024-11-015210123810.1016/j.lanwpc.2024.101238Progress and challenges of confirmatory trials for cancer drugs granted conditional approval in ChinaXingxian Luo0Yang Xu1Xin Du2Xufeng Lv3Si Chen4Yue Yang5Lin Huang6Xiaohong Zhang7Department of Pharmacy, Peking University People's Hospital, Beijing, ChinaSchool of Pharmaceutical Sciences, Tsinghua University, Beijing, China; Key Laboratory of Innovative Drug Research and Evaluation, National Medical Products Administration, Beijing, ChinaVanke School of Public Health, Tsinghua University, Beijing, ChinaCenter for Drug Evaluation, National Medical Products Administration, Beijing, ChinaCenter for Drug Evaluation, National Medical Products Administration, Beijing, ChinaSchool of Pharmaceutical Sciences, Tsinghua University, Beijing, China; Key Laboratory of Innovative Drug Research and Evaluation, National Medical Products Administration, Beijing, China; Corresponding author. School of Pharmaceutical Sciences, Tsinghua University, Beijing, China.Department of Pharmacy, Peking University People's Hospital, Beijing, China; Corresponding author.Department of Pharmacy, Peking University People's Hospital, Beijing, China; Corresponding author.http://www.sciencedirect.com/science/article/pii/S2666606524002323
spellingShingle Xingxian Luo
Yang Xu
Xin Du
Xufeng Lv
Si Chen
Yue Yang
Lin Huang
Xiaohong Zhang
Progress and challenges of confirmatory trials for cancer drugs granted conditional approval in China
The Lancet Regional Health. Western Pacific
title Progress and challenges of confirmatory trials for cancer drugs granted conditional approval in China
title_full Progress and challenges of confirmatory trials for cancer drugs granted conditional approval in China
title_fullStr Progress and challenges of confirmatory trials for cancer drugs granted conditional approval in China
title_full_unstemmed Progress and challenges of confirmatory trials for cancer drugs granted conditional approval in China
title_short Progress and challenges of confirmatory trials for cancer drugs granted conditional approval in China
title_sort progress and challenges of confirmatory trials for cancer drugs granted conditional approval in china
url http://www.sciencedirect.com/science/article/pii/S2666606524002323
work_keys_str_mv AT xingxianluo progressandchallengesofconfirmatorytrialsforcancerdrugsgrantedconditionalapprovalinchina
AT yangxu progressandchallengesofconfirmatorytrialsforcancerdrugsgrantedconditionalapprovalinchina
AT xindu progressandchallengesofconfirmatorytrialsforcancerdrugsgrantedconditionalapprovalinchina
AT xufenglv progressandchallengesofconfirmatorytrialsforcancerdrugsgrantedconditionalapprovalinchina
AT sichen progressandchallengesofconfirmatorytrialsforcancerdrugsgrantedconditionalapprovalinchina
AT yueyang progressandchallengesofconfirmatorytrialsforcancerdrugsgrantedconditionalapprovalinchina
AT linhuang progressandchallengesofconfirmatorytrialsforcancerdrugsgrantedconditionalapprovalinchina
AT xiaohongzhang progressandchallengesofconfirmatorytrialsforcancerdrugsgrantedconditionalapprovalinchina